Taiyen Biotech Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 05, 2021
Share
Taiyen Biotech Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 986.096 million compared to TWD 790.850 million a year ago. Operating income was TWD 144.141 million compared to TWD 98.428 million a year ago. Net income was TWD 106.861 million compared to TWD 81.788 million a year ago. Basic earnings per share from continuing operations was TWD 0.53 compared to TWD 0.41 a year ago. For the half year, sales was TWD 1,776.181 million compared to TWD 1,515.307 million a year ago. Operating income was TWD 273.590 million compared to TWD 195.322 million a year ago. Net income was TWD 209.424 million compared to TWD 147.638 million a year ago. Basic earnings per share from continuing operations was TWD 1.05 compared to TWD 0.74 a year ago.
Taiyen Biotech Co., Ltd is a Taiwan-based company mainly engaged in the manufacture, distribution and trading of salt products, salt by-products and other salt derivatives. The Company offers salt products, skin care and cosmetics, bottled water products, facial and body cleansers, health and dietary supplements, as well as other products, such as collagen raw materials, biomedical materials, microbial agents and others. The Companyâs salt products include fine salts, dried salts, low sodium salts, bay salts and other salts, which are applied in industry, agriculture, food processing, cooking and others. The Company distributes its products in Taiwan market and to overseas markets.
TAIYEN BIOTECH CO., LTD. 
